Loading...

Zealand Pharma A/S

ZLDPF•PNK
Healthcare
Biotechnology
$49.00
$1.53(3.22%)
U.S. Market opens in 2h 9m

Zealand Pharma A/S (ZLDPF) Stock Overview

Explore Zealand Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E Ratio3.43
EPS (TTM)$14.13
ROE0.48%
Fundamental Analysis

AI Price Forecasts

1 Month$9.09
3 Months$19.14
1 Year Target$107.46

ZLDPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zealand Pharma A/S (ZLDPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $107.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3.43 and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.22%
5-Day Change
3.22%
1-Month Change
10.24%
3-Month Change
-27.68%
6-Month Change
-31.19%
Year-to-Date (YTD) Change
-31.56%
1-Year Change
-26.80%
3-Year Change
46.71%
5-Year Change
50.31%
All-Time (Max) Change
246.78%

Contact Information

45 88 77 36 00
Sydmarken 11, Copenhagen, NaN, 2860

Company Facts

385 Employees
IPO DateFeb 25, 2013
CountryDK
Actively Trading

Frequently Asked Questions